Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease. - Wikidata - awgldk - TriplyDB

Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease.

Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease.

http://www.wikidata.org/entity/Q30389327

about

Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?Quantitative Imaging Biomarkers of NAFLD Hepatic steatosis and fibrosis: Non-invasive assessment.Noninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver Disease.Liver fat: a relevant target for dietary intervention? Summary of a Unilever workshop Ectopic and Visceral Fat Deposition in Lean and Obese Patients With Type 2 Diabetes Noninvasive diagnosis of nonalcoholic fatty liver disease: Are we there yet?Non-alcoholic fatty liver disease in 2016.Multiparametric or practical quantitative liver MRI: towards millisecond, fat fraction, kilopascal and function era.Magnetic resonance imaging and transient elastography in the management of Nonalcoholic Fatty Liver Disease (NAFLD).Invasive and non-invasive assessment of portal hypertension.Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity.Nonalcoholic fatty liver disease: Evolving paradigms.Role of imaging-based biomarkers in NAFLD: Recent advances in clinical application and future research directions.Utility and cost evaluation of multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease.Chronic hepatitis B: correlation of abnormal features on T2-weighted imaging and dynamic contrast-enhanced imaging with hepatic histopathology.Digital liver biopsy: Bio-imaging of fatty liver for translational and clinical research.A model for hepatic fibrosis: the competing effects of cell loss and iron on shortened modified Look-Locker inversion recovery T1 (shMOLLI-T1 ) in the liver.Prevalent Cardiovascular Disease Events and T1 Mapping Defined Hepatic Fibrosis.Multiparametric magnetic resonance imaging in patients with chronic liver disease: are we there yet?Multiparametric magnetic resonance imaging for quantitation of liver disease: a two-centre cross-sectional observational study.Noninvasive Quantitative Detection Methods of Liver Fat Content in Nonalcoholic Fatty Liver Disease.Study protocol: HepaT1ca - an observational clinical cohort study to quantify liver health in surgical candidates for liver malignancies Validation of a standardized MRI method for liver fat and T2* quantification

P2860

Q26744631-6AE600BF-E8BE-4DE0-94E9-B233577533FE Q26768664-C5AA2A1A-A0E3-4CA3-92BD-020528DB7228 Q28077200-F4975CB4-1499-4EA8-AE30-29026684BC3D Q30355082-28D4C2B4-EAE4-42E5-B0AF-669E1DAEFC04 Q33791133-044852A2-ED80-41B9-BF8A-9B3AB36C6C17 Q37048666-F6872D06-8FB4-4386-9658-C5FCBC335DC4 Q38772737-FDB279D6-765D-4FFE-8551-8D5FD9C88C14 Q38932554-D0A49941-CEF8-469E-92C0-573F99428A37 Q39034532-3E22585D-451D-46B3-AD4E-55D34B2F5B95 Q39170830-A9B7D429-BAA9-4248-B28D-D851B137CB5C Q39210299-A3B3AFB5-09E8-4FCF-9F3E-362BEC00D71E Q39251875-7087C686-203F-4D4E-B2D8-DF54A99CDA57 Q42695154-CC7F83CD-B02C-4B6D-B6E1-08707150690C Q46476704-637857CD-C687-4734-BE7F-2E01A504D7D6 Q47260332-7FBC600E-9F5D-498E-9883-1E570690384D Q51829317-859815F9-2C03-4144-A24C-938A1DF84DBE Q52661700-047A22E3-9B5C-4586-A493-EBFC1664797F Q53062749-BF4C234A-D120-447A-B8F4-1C6CEEB1DFC3 Q53703261-C33F5D7F-BB5C-41BB-AEE0-796BC9EE7FC7 Q54717572-DD33C3EC-1109-4C86-9462-67C50E71EDFF Q55379833-972A112F-F623-4EDA-B44B-4C4C68F86776 Q55402878-00EC7333-F3DB-4035-BA6E-FBDD72D726E7 Q57157834-1E94F467-7FD9-4B13-BE69-E46F976CA4DD Q58713260-9F499519-9911-41BB-8868-8A36750C9B89

P2860

Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease.

http://www.wikidata.org/entity/Q30389327

description

2015 nî lūn-bûn

@nan

2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Multiparametric magnetic reson ...... ts with chronic liver disease.

@ast

Multiparametric magnetic reson ...... ts with chronic liver disease.

@en

type

label

Multiparametric magnetic reson ...... ts with chronic liver disease.

@ast

Multiparametric magnetic reson ...... ts with chronic liver disease.

@en

prefLabel

Multiparametric magnetic reson ...... ts with chronic liver disease.

@ast

Multiparametric magnetic reson ...... ts with chronic liver disease.

@en

P1433

Q30389327-E8C8BBA6-3CC4-4208-9C60-966C6AC6D1C0

P1476

Q30389327-DC78F52F-648B-4D50-BD85-51360FF4027A

P2093

Q30389327-14B9FFCB-9CE7-48C6-BBB2-2A196794708A

Q30389327-2A56CC8B-B84E-415A-A5B6-D190FB9C360E

Q30389327-3869848C-E973-4F85-A954-427D8EFB455D

Q30389327-475911C1-B678-4E1E-8077-84665B86AE4D

Q30389327-A813F628-7EA6-49ED-B90C-9245D6A177B7

Q30389327-AA117209-BCDC-461C-BDDD-7C019719A6F4

Q30389327-DD3C1235-6823-4C65-B5E7-EB9EE67E2FBC

P2860

Q30389327-06CA4AFF-AFF7-4C63-99F6-B3FFAA2BBECC

Q30389327-28C34D8D-D8B3-488B-8388-B52CEF7CF5FC

Q30389327-2E9C4074-CB06-4372-9843-314FD5F62927

Q30389327-3A285003-52F9-4762-91B1-B57D2C0491E1

Q30389327-40DD9D6C-775A-4A52-9BC1-6C9523FA989E

Q30389327-41AC8BDF-CC70-42B5-B0DE-E329703E9E62

Q30389327-608F333C-BA90-40BC-A270-1C3C7AE7B89D

Q30389327-677BDA60-292A-4B7C-A80F-60EE1EC3D42F

Q30389327-6F893F6F-1285-45CD-AFB2-2D1069C5CA75

Q30389327-73F6B792-ACBE-42F7-8E0C-616257E08CBB

P304

Q30389327-1CCE1C87-EDDF-4BAF-A866-70D073A20470

P31

Q30389327-4066155A-B941-4DA6-8F6C-349BF1356571

P356

Q30389327-A10DD571-6DDC-44BA-9FAA-39FA7FAC0F10

P433

Q30389327-96006BEE-3E02-4C08-8A02-3BF0229AAB34

P478

Q30389327-0E37D867-5720-453F-85A7-9A4B4BF00021

P50

Q30389327-25CF3660-3384-47C2-8CA8-620C046B28F3

Q30389327-C1B97625-D54F-4D38-89B9-6592D759BE8C

P577

Q30389327-51C96B23-300D-4F35-8382-A64024E14654

P5875

Q30389327-D6435FC5-DD45-466E-9B6C-8BD92559815B

P698

Q30389327-19F73228-2DE5-4C18-941A-CC8BCD4C414F

P932

Q30389327-8095992B-3A52-4F01-96C8-F3784492AD32

P356

J.JHEP.2015.10.009

P1433

Journal of Hepatology

P1476

Multiparametric magnetic reson ...... ts with chronic liver disease.

@en

P2093

Catherine J Kelly

http://www.w3.org/2001/XMLSchema#string

Jane Collier

http://www.w3.org/2001/XMLSchema#string

Joanne Sellwood

http://www.w3.org/2001/XMLSchema#string

Jonathan C Booth

http://www.w3.org/2001/XMLSchema#string

Matthew D Robson

http://www.w3.org/2001/XMLSchema#string

Rajarshi Banerjee

http://www.w3.org/2001/XMLSchema#string

Stefan Neubauer

http://www.w3.org/2001/XMLSchema#string

P2860

Liver iron is predictive of death in alcoholic cirrhosis: a multivariate study of 229 consecutive patients with alcoholic and/or hepatitis C virus cirrhosis: a prospective follow up study

Global epidemiology of hepatitis C virus infection

Strategies and endpoints of antifibrotic drug trials: Summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014.

Histological grading and staging of chronic hepatitis

Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data.

Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)

Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease.

Repeatability of magnetic resonance elastography for quantification of hepatic stiffness.

Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers.

MRI-based estimation of liver function: Gd-EOB-DTPA-enhanced T1 relaxometry of 3T vs. the MELD score.

P304

308-315

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JHEP.2015.10.009

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P50

Michael Pavlides

P577

2015-10-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282912001

http://www.w3.org/2001/XMLSchema#string

P698

26471505

http://www.w3.org/2001/XMLSchema#string

P932

4751288

http://www.w3.org/2001/XMLSchema#string